← Eichor
Condition: Heartburn Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Heartburn

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Heartburn, Gastroesophageal Reflux Disease
Phase 4 · 10 location(s) · Incheon St.Mary's Hospital · NCT07268820Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
Phase N/A · 2 location(s) · University of Pittsburgh · NCT00260559A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
Phase N/A · 1 location(s) · Phathom Pharmaceuticals, Inc. · NCT06660342Evaluating the Impact of Various Dietary Nitrate Supplements on Oral Health
NA · 1 location(s) · Shatha Alhulaefi · NCT06956612Domperidone in Treating Patients With Gastrointestinal Disorders
Phase 3 · 1 location(s) · M.D. Anderson Cancer Center · NCT01696734Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg
NA · 2 location(s) · Valenta Pharm JSC · NCT06098742New Topical tReatment Options for Symptomatic patiEnts With Nonerosive gastroesophageaL Reflux dIsease (The RELIEF Trial
NA · 1 location(s) · Cellmedis · NCT07624383A Study of Breath Testing for Small Intestinal Bacterial Overgrowth
NA · 1 location(s) · Mayo Clinic · NCT05976165Study on Hydrotalcite for Relief of Acid Symptoms Due to Acid Rebound After Stopping Long-Term PPI Therapy
Phase N/A · 2 location(s) · Bayer · NCT07291700
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.